Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical ADV-VSTS for Refractory Adenovirus Infection
NCT04722029Phase 2Recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of adenovirus-specific T lymphocytes in adenovirus infection, sponsored by Nationwide Children's Hospital. Started Oct 2021; status: recruiting.
02
Drugs
adenovirus-specific T lymphocytes
03
Conditions
adenovirus infection
Beyond the preview
Go deeper on NCT04722029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04722029.